It’s part of a larger battle between Louisiana officials and big health care companies over prescription drug prices.

CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock ...

CVS Health on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady ...

CVS Health’s stock rose more than 2% on Tuesday after the company boosted its revenue and profit guidance for the year and ...

CVS Health Corp. raised its full-year profit forecast and said earnings would rise in 2026, a sign of hope as it navigates a ...

The healthcare giant expects its turnaround efforts to pay off as it raised its full-year outlook and expects that momentum ...

A Florida judge on Monday declared a mistrial in a lawsuit that accused Walmart, CVS and Walgreens of flooding the state with ...

CVS Health expects 2026 profit to beat Wall Street estimates and this year's projected earnings, it said on Tuesday, ...

CVS Health issued an update to its full-year guidance Tuesday ahead of its annual investor day, pointing to stronger ...

CVS is a strong buy now, with rising earnings, solid dividends, and steady growth prospects despite industry challenges. Read ...

In addition to the updates for 2025, CVS offered its first look at expected earnings for 2026. The company said it ...